A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
Teramoto
S
S
Fukuchi
Y
Y
Ouchi
Y
Y
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000420:Albuterol / Q000008:administration & dosage*; D018680:Cholinergic Antagonists / Q000008:administration & dosage*; D004417:Dyspnea / Q000503:physiopathology; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D005082:Physical Exertion
D000318:Adrenergic beta-Agonists; D018680:Cholinergic Antagonists; D009241:Ipratropium; D000420:Albuterol